BioXcel Therapeutics, Inc.
BTAIQ
$0.05
$0.009.56%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -26.35% | -44.60% | -4.82% | -10.43% | -69.02% |
| Total Receivables | 382.35% | -- | 77.86% | -- | -97.91% |
| Inventory | -4.55% | -22.12% | 6.33% | -69.90% | -81.12% |
| Prepaid Expenses | -40.31% | -16.72% | -23.86% | 27.04% | 85.59% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 472.37% | 771.26% | 683.82% | 48.64% | 29.95% |
| Total Current Assets | 13.69% | -10.24% | 19.50% | -7.09% | -60.67% |
|
|
|||||
| Total Current Assets | 13.69% | -10.24% | 19.50% | -7.09% | -60.67% |
| Net Property, Plant & Equipment | -81.87% | -83.33% | -73.05% | -61.60% | -53.21% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 11.67% | -11.77% | 17.16% | -8.39% | -60.59% |
|
|
|||||
| Total Accounts Payable | 12.53% | 5.16% | -8.06% | 9.32% | 25.92% |
| Total Accrued Expenses | -20.89% | 66.67% | -23.04% | -49.49% | -62.18% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 810.49% | 276.49% | -- | 4,515.22% | 3,077.84% |
| Total Finance Division Other Current Liabilities | 9,045.37% | 4,234.51% | 2,003.66% | -90.02% | -38.98% |
| Total Other Current Liabilities | 9,045.37% | 4,234.51% | 2,003.66% | -90.02% | -38.98% |
| Total Current Liabilities | 310.92% | 115.27% | 142.55% | 47.92% | 22.31% |
|
|
|||||
| Total Current Liabilities | 310.92% | 115.27% | 142.55% | 47.92% | 22.31% |
| Long-Term Debt | -- | -22.08% | -17.41% | -11.62% | -5.38% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 172.31% | 105.13% | -73.01% | -17.45% | -71.58% |
| Total Liabilities | 8.09% | 8.41% | 6.80% | -0.61% | -4.49% |
|
|
|||||
| Common Stock & APIC | 11.08% | 10.57% | 12.12% | 11.73% | 3.19% |
| Retained Earnings | -10.47% | -11.46% | -10.75% | -10.67% | -8.14% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -7.24% | -17.05% | -2.54% | -3.84% | -44.91% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -7.24% | -17.05% | -2.54% | -3.84% | -44.91% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.24% | -17.05% | -2.54% | -3.84% | -44.91% |
|
|
|||||